American Journal of Medical Genetics Part A, ISSN 1552-4825, 2015, Volume 167, Issue 2, pp. 296 - 312
Aicardi-Goutières syndrome is an inflammatory disease occurring due to mutations in any of TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR or IFIH1. We...
spastic paraparesis | type I interferon | bilateral striatal necrosis | interferon signature | Aicardi–Goutières syndrome | Interferon signature | Bilateral striatal necrosis | Spastic paraparesis | Type I interferon | Aicardi-Goutières syndrome | SYSTEMIC-LUPUS-ERYTHEMATOSUS | BASAL GANGLIA | ENCEPHALOPATHY | AICARDI-GOUTIERES-SYNDROME | INTERFERON-ALPHA | GENE | Aicardi-Goutieres syndrome | DNA EXONUCLEASE TREX1 | GENETICS & HEREDITY | CLASSIFICATION-SYSTEM | VASCULOPATHY | CALCIFICATIONS | Interferons - cerebrospinal fluid | Genetic Association Studies | Adenosine Deaminase - genetics | Humans | SAM Domain and HD Domain-Containing Protein 1 | Genotype | Monomeric GTP-Binding Proteins - genetics | Phosphoproteins - genetics | Pterins - cerebrospinal fluid | Interferon-Induced Helicase, IFIH1 | DEAD-box RNA Helicases - genetics | Phenotype | Interferons - blood | Autoimmune Diseases of the Nervous System - genetics | Nervous System Malformations - diagnosis | Exodeoxyribonucleases - genetics | Mutation | Nervous System Malformations - genetics | Autoimmune Diseases of the Nervous System - diagnosis | Ribonuclease H - genetics | Glaucoma | Mortality | Skin diseases | Genetic aspects | Hypothyroidism | Biological response modifiers
spastic paraparesis | type I interferon | bilateral striatal necrosis | interferon signature | Aicardi–Goutières syndrome | Interferon signature | Bilateral striatal necrosis | Spastic paraparesis | Type I interferon | Aicardi-Goutières syndrome | SYSTEMIC-LUPUS-ERYTHEMATOSUS | BASAL GANGLIA | ENCEPHALOPATHY | AICARDI-GOUTIERES-SYNDROME | INTERFERON-ALPHA | GENE | Aicardi-Goutieres syndrome | DNA EXONUCLEASE TREX1 | GENETICS & HEREDITY | CLASSIFICATION-SYSTEM | VASCULOPATHY | CALCIFICATIONS | Interferons - cerebrospinal fluid | Genetic Association Studies | Adenosine Deaminase - genetics | Humans | SAM Domain and HD Domain-Containing Protein 1 | Genotype | Monomeric GTP-Binding Proteins - genetics | Phosphoproteins - genetics | Pterins - cerebrospinal fluid | Interferon-Induced Helicase, IFIH1 | DEAD-box RNA Helicases - genetics | Phenotype | Interferons - blood | Autoimmune Diseases of the Nervous System - genetics | Nervous System Malformations - diagnosis | Exodeoxyribonucleases - genetics | Mutation | Nervous System Malformations - genetics | Autoimmune Diseases of the Nervous System - diagnosis | Ribonuclease H - genetics | Glaucoma | Mortality | Skin diseases | Genetic aspects | Hypothyroidism | Biological response modifiers
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 12/2012, Volume 21, Issue 24, pp. 5359 - 5372
Genetic generalized epilepsies (GGEs) have a lifetime prevalence of 0.3 and account for 2030 of all epilepsies. Despite their high heritability of 80, the...
VISUALIZATION | INDEPENDENT TESTS | REPLICATION | JUVENILE MYOCLONIC EPILEPSY | MICRODELETIONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | ARCHITECTURE | RISK | MECHANISMS | MUTATIONS | SEIZURE TYPES | Epilepsy, Generalized - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Humans | NAV1.1 Voltage-Gated Sodium Channel - genetics | Protein-Serine-Threonine Kinases - genetics | Epilepsy, Absence - genetics | Repressor Proteins - genetics | Receptor, Muscarinic M3 - genetics | Zinc Finger E-box Binding Homeobox 2 | Homeodomain Proteins - genetics | Myoclonic Epilepsy, Juvenile - genetics | Alleles
VISUALIZATION | INDEPENDENT TESTS | REPLICATION | JUVENILE MYOCLONIC EPILEPSY | MICRODELETIONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | ARCHITECTURE | RISK | MECHANISMS | MUTATIONS | SEIZURE TYPES | Epilepsy, Generalized - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Humans | NAV1.1 Voltage-Gated Sodium Channel - genetics | Protein-Serine-Threonine Kinases - genetics | Epilepsy, Absence - genetics | Repressor Proteins - genetics | Receptor, Muscarinic M3 - genetics | Zinc Finger E-box Binding Homeobox 2 | Homeodomain Proteins - genetics | Myoclonic Epilepsy, Juvenile - genetics | Alleles
Journal Article
Genetics in Medicine, ISSN 1098-3600, 02/2019, Volume 21, Issue 2, pp. 398 - 408
Purpose: To define the phenotypic and mutational spectrum of epilepsies related to DEPDC5, NPRL2 and NPRL3 genes encoding the GATOR1 complex, a negative...
Genetic focal epilepsy | mTORC1 pathway | Focal cortical dysplasia | SUDEP | DEPDC5 | FAMILIAL FOCAL EPILEPSY | MAMMALIAN TARGET | CORTICAL DYSPLASIA | COMPLEX | DEPDC5 MUTATIONS | MODEL | SUDDEN UNEXPECTED DEATH | GTPASES | GENETICS | GENES | GENETICS & HEREDITY | Life Sciences | Genetics | Human genetics | focal cortical dysplasia | genetic focal epilepsy
Genetic focal epilepsy | mTORC1 pathway | Focal cortical dysplasia | SUDEP | DEPDC5 | FAMILIAL FOCAL EPILEPSY | MAMMALIAN TARGET | CORTICAL DYSPLASIA | COMPLEX | DEPDC5 MUTATIONS | MODEL | SUDDEN UNEXPECTED DEATH | GTPASES | GENETICS | GENES | GENETICS & HEREDITY | Life Sciences | Genetics | Human genetics | focal cortical dysplasia | genetic focal epilepsy
Journal Article
Infection, ISSN 0300-8126, 4/2016, Volume 44, Issue 2, pp. 259 - 262
We report an unusual case of acute acquired toxoplasmosis (AAT) presenting as lymphadenopathy and recurrent seizures in an immunocompetent 15-year-old boy.The...
Travel | Toxoplasma gondii | Medicine & Public Health | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Seizure | Immunocompetent | Acute acquired toxoplasmosis | INFECTIOUS DISEASES | GONDII | Toxoplasma - immunology | Recurrence | Immunoglobulin G - blood | Humans | Sulfadiazine - therapeutic use | Male | Antibodies, Protozoan - blood | Seizures - pathology | Toxoplasmosis - complications | Leucovorin - therapeutic use | Valproic Acid - therapeutic use | Pyrimethamine - therapeutic use | Anticonvulsants - therapeutic use | Toxoplasmosis - diagnosis | Seizures - diagnosis | Treatment Outcome | Epilepsy - complications | Epilepsy - diagnosis | Toxoplasmosis - pathology | Immunoglobulin M - blood | Adolescent | Antiprotozoal Agents - therapeutic use | Epilepsy - pathology | Ethiopia | Complications and side effects | Care and treatment | Seizures (Medicine) | Research | Toxoplasmosis | Risk factors
Travel | Toxoplasma gondii | Medicine & Public Health | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Seizure | Immunocompetent | Acute acquired toxoplasmosis | INFECTIOUS DISEASES | GONDII | Toxoplasma - immunology | Recurrence | Immunoglobulin G - blood | Humans | Sulfadiazine - therapeutic use | Male | Antibodies, Protozoan - blood | Seizures - pathology | Toxoplasmosis - complications | Leucovorin - therapeutic use | Valproic Acid - therapeutic use | Pyrimethamine - therapeutic use | Anticonvulsants - therapeutic use | Toxoplasmosis - diagnosis | Seizures - diagnosis | Treatment Outcome | Epilepsy - complications | Epilepsy - diagnosis | Toxoplasmosis - pathology | Immunoglobulin M - blood | Adolescent | Antiprotozoal Agents - therapeutic use | Epilepsy - pathology | Ethiopia | Complications and side effects | Care and treatment | Seizures (Medicine) | Research | Toxoplasmosis | Risk factors
Journal Article
The Lancet Neurology, ISSN 1474-4422, 08/2018, Volume 17, Issue 8, pp. 699 - 708
Background: Genetic generalised epilepsy is the most common type of inherited epilepsy. Despite a high concordance rate of 80% in monozygotic twins, the...
15Q13.3 MICRODELETIONS | ASSOCIATION ANALYSIS | DE-NOVO MUTATIONS | EPILEPTIC ENCEPHALOPATHIES | SEQUENCE DATA | MOUSE MODEL | RISK | GAMMA-2-SUBUNIT | FEBRILE SEIZURES | CLINICAL NEUROLOGY | ABSENCE EPILEPSY | Biomedical research | Disease | γ-Aminobutyric acid A receptors | Research & development--R&D | Epilepsy | Genomics | Genes | Genomes | Oocytes | Defects | Studies | Consortia | Genetic variance | Hypotheses | γ-Aminobutyric acid | Quality control | Replication
15Q13.3 MICRODELETIONS | ASSOCIATION ANALYSIS | DE-NOVO MUTATIONS | EPILEPTIC ENCEPHALOPATHIES | SEQUENCE DATA | MOUSE MODEL | RISK | GAMMA-2-SUBUNIT | FEBRILE SEIZURES | CLINICAL NEUROLOGY | ABSENCE EPILEPSY | Biomedical research | Disease | γ-Aminobutyric acid A receptors | Research & development--R&D | Epilepsy | Genomics | Genes | Genomes | Oocytes | Defects | Studies | Consortia | Genetic variance | Hypotheses | γ-Aminobutyric acid | Quality control | Replication
Journal Article
GENETICS IN MEDICINE, ISSN 1098-3600, 07/2019, Volume 21, Issue 7, pp. 1671 - 1671
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, pp. e0180470 - e0180470
Epilepsy is the most common comorbidity in patients with brain tumors. Study Aims: To define characteristics of brain tumor-related epilepsy (BTRE) patients...
PROPHYLAXIS | IMPACT | MANAGEMENT | HOSPITAL VOLUME | EFFICACY | GLIOBLASTOMA-MULTIFORME | MULTIDISCIPLINARY SCIENCES | CANCER CARE | VOLUME-OUTCOME RELATIONSHIP | ANTIEPILEPTIC DRUG | LEVETIRACETAM | Humans | Anticonvulsants - therapeutic use | Male | Risk | Treatment Outcome | Brain Neoplasms - complications | Epilepsy - complications | Survival Analysis | Adult | Epilepsy - drug therapy | Female | Italy | Patient Care - statistics & numerical data | Retrospective Studies | Psychological aspects | Complications and side effects | Care and treatment | Brain tumors | Epilepsy | Research | Diagnosis | Risk factors | Drugs | Brain | Enzymes | Toxicity | Brain cancer | Sex | Medical records | Radiation therapy | Antiepileptic agents | Patients | Etiracetam | Angiogenesis | Side effects | Convulsions & seizures | Chemotherapy | Surgery | Quality control | Seizures | Tumors | Index Medicus
PROPHYLAXIS | IMPACT | MANAGEMENT | HOSPITAL VOLUME | EFFICACY | GLIOBLASTOMA-MULTIFORME | MULTIDISCIPLINARY SCIENCES | CANCER CARE | VOLUME-OUTCOME RELATIONSHIP | ANTIEPILEPTIC DRUG | LEVETIRACETAM | Humans | Anticonvulsants - therapeutic use | Male | Risk | Treatment Outcome | Brain Neoplasms - complications | Epilepsy - complications | Survival Analysis | Adult | Epilepsy - drug therapy | Female | Italy | Patient Care - statistics & numerical data | Retrospective Studies | Psychological aspects | Complications and side effects | Care and treatment | Brain tumors | Epilepsy | Research | Diagnosis | Risk factors | Drugs | Brain | Enzymes | Toxicity | Brain cancer | Sex | Medical records | Radiation therapy | Antiepileptic agents | Patients | Etiracetam | Angiogenesis | Side effects | Convulsions & seizures | Chemotherapy | Surgery | Quality control | Seizures | Tumors | Index Medicus
Journal Article
Epilepsy Research, ISSN 0920-1211, 2013, Volume 108, Issue 2, pp. 340 - 344
Highlights • Sanger sequencing was applied in KCNT1, PLCB1, SCN1A and TBC1D24 loci. • None of the reported mutations was present in six patients with MMPEI. •...
Neurology | TBC1D24 | Targeted re-sequencing | KCNT1 | PLCB1 | MMPSI | SCN1A | SODIUM | MIGRATING PARTIAL SEIZURES | DISORDER | POTASSIUM | INFANCY | CLINICAL NEUROLOGY | Sequence Deletion | Epilepsies, Partial - diagnosis | Humans | NAV1.1 Voltage-Gated Sodium Channel - genetics | Infant | Male | Mutation - genetics | Nerve Tissue Proteins - genetics | Phospholipase C beta - genetics | Potassium Channels - genetics | Genetic Variation | Carrier Proteins - genetics | Phenotype | Female | Epilepsies, Partial - genetics
Neurology | TBC1D24 | Targeted re-sequencing | KCNT1 | PLCB1 | MMPSI | SCN1A | SODIUM | MIGRATING PARTIAL SEIZURES | DISORDER | POTASSIUM | INFANCY | CLINICAL NEUROLOGY | Sequence Deletion | Epilepsies, Partial - diagnosis | Humans | NAV1.1 Voltage-Gated Sodium Channel - genetics | Infant | Male | Mutation - genetics | Nerve Tissue Proteins - genetics | Phospholipase C beta - genetics | Potassium Channels - genetics | Genetic Variation | Carrier Proteins - genetics | Phenotype | Female | Epilepsies, Partial - genetics
Journal Article
GENETICS IN MEDICINE, ISSN 1098-3600, 08/2019, Volume 21, Issue 8, pp. 1896 - 1896
Journal Article
JAMA, ISSN 0098-7484, 04/2013, Volume 309, Issue 15, pp. 1607 - 1612
IMPORTANCE Infantile colic is a common cause of inconsolable crying during the first months of life and has been thought to be a pain syndrome. Migraine is a...
TRIAL | MEDICINE, GENERAL & INTERNAL | PAIN | HEADACHE | ADOLESCENCE | PREVALENCE | CHILDREN | Medical History Taking | France - epidemiology | Prevalence | Humans | Infant | Male | Risk | Emergency Service, Hospital - statistics & numerical data | Case-Control Studies | Adolescent | Female | Italy - epidemiology | Odds Ratio | Child | Colic - epidemiology | Infant, Newborn | Migraine Disorders - epidemiology | Migraine in children | Research | Children | Migraine | Colic | Diseases | Medical research | Children & youth
TRIAL | MEDICINE, GENERAL & INTERNAL | PAIN | HEADACHE | ADOLESCENCE | PREVALENCE | CHILDREN | Medical History Taking | France - epidemiology | Prevalence | Humans | Infant | Male | Risk | Emergency Service, Hospital - statistics & numerical data | Case-Control Studies | Adolescent | Female | Italy - epidemiology | Odds Ratio | Child | Colic - epidemiology | Infant, Newborn | Migraine Disorders - epidemiology | Migraine in children | Research | Children | Migraine | Colic | Diseases | Medical research | Children & youth
Journal Article
Epilepsia, ISSN 0013-9580, 02/2012, Volume 53, Issue 2, pp. 308 - 318
Summary Purpose: Genetic generalized epilepsies (GGEs) have a lifetime prevalence of 0.3% with heritability estimates of 80%. A considerable proportion of...
Genetic generalized epilepsy | Complex inheritance | Myoclonic seizure | Absence seizure | Linkage analysis | I ERROR | CLINICAL NEUROLOGY | CHILDHOOD ABSENCE EPILEPSY | HETEROGENEITY | SEIZURES | JUVENILE MYOCLONIC EPILEPSY | FAMILIES | ARCHITECTURE | CHROMOSOME-6 | COMPLEX TRAITS | ASSOCIATION | Epilepsy, Generalized - genetics | Chromosomes, Human, Pair 13 - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Humans | Genotype | Male | Chromosome Mapping | Genetic Loci | Chromosomes, Human, Pair 2 - genetics | Phenotype | Pedigree | Family | Female | Genetic Linkage | Medical colleges | Neurosciences | Genomics | Epilepsy | Genes | Genomes | Disease susceptibility | Risk factors | Bad debts | Analysis | Medical genetics | Genetic research | Seizures (Medicine) | Medical research | Reviews | chromosome 2 | Heritability | Models | Genetic factors | Polygenic inheritance | Genotypes | Seizures | Siblings
Genetic generalized epilepsy | Complex inheritance | Myoclonic seizure | Absence seizure | Linkage analysis | I ERROR | CLINICAL NEUROLOGY | CHILDHOOD ABSENCE EPILEPSY | HETEROGENEITY | SEIZURES | JUVENILE MYOCLONIC EPILEPSY | FAMILIES | ARCHITECTURE | CHROMOSOME-6 | COMPLEX TRAITS | ASSOCIATION | Epilepsy, Generalized - genetics | Chromosomes, Human, Pair 13 - genetics | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Humans | Genotype | Male | Chromosome Mapping | Genetic Loci | Chromosomes, Human, Pair 2 - genetics | Phenotype | Pedigree | Family | Female | Genetic Linkage | Medical colleges | Neurosciences | Genomics | Epilepsy | Genes | Genomes | Disease susceptibility | Risk factors | Bad debts | Analysis | Medical genetics | Genetic research | Seizures (Medicine) | Medical research | Reviews | chromosome 2 | Heritability | Models | Genetic factors | Polygenic inheritance | Genotypes | Seizures | Siblings
Journal Article